National Research Q2 revenue up 17% to $36.4M; EPS rises to $0.35 from $0.30

NRC HEALTH

2021-Q2 EPS reported $0.71 revenue$71,889,000

Total Recurring Contract Value grew 5% YoY to $149.8M.
Operating income increased 32% to $12.2M; net income $8.9M vs $7.7M.
Voice of the Customer revenue up 29% YoY; new clients include The Oregon Clinic and Foundation Health Partners.
Cash balance $48.9M; management plans to use liquidity for M&A and dividends.
Diluted EPS $0.35 for Q2 2021, up from $0.30 in Q2 2020.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.